You need to enable JavaScript to run this app. RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use ...

Expert speakers. Interactive sessions. Insights that really help. Convergence offers 150+ educational and networking sessions where expert speakers share insights designed to help you at every stage ...

Principal Medical Device Regulatory Expert, Hyman, Phelps & McNamara, P.C. Division Director, Division of Regulatory Operations and Programs (DROP), Office of Regulatory Operations (ORO), Center for ...

RAPS has negotiated discounted rates at various hotels in Pittsburgh. Reserve your hotel stay by 30 September for the best availability. RAPS has designated MCI USA as the only housing provider for ...

Where the regulatory community gathers to discuss the topics you want to learn, with expert speakers offering practical insights you can apply right away.

Take Part in a Dynamic Regulatory Conference in Pittsburgh! Regulatory professionals rely on RAPS Convergence for essential updates, dynamic collaboration opportunities, and timely professional ...

10:35 am – 12:25 pm Solutions Circles in the Exhibit Hall 10:45 am – 12:55 pm Sponsor Theater Presentations in the Exhibit Hall ...

A certification or certificate can help you showcase your regulatory affairs knowledge, stand out from your peers and advance your career. Although the terms certificate and certification seem similar ...

Jumpstart your regulatory career at RAPS Convergence! The RAPS Convergence Student Program helps emerging professionals (students currently enrolled in university and recent graduates) explore career ...

Take Part in a Dynamic Regulatory Conference in Pittsburgh! Regulatory professionals rely on RAPS Convergence for essential updates, dynamic collaboration opportunities, and timely professional ...

You need to enable JavaScript to run this app. RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use ...

FDA Issues Draft Guidance for Industry: Presenting Risk Information in Prescription Drug and Medical Device Promotion ...